Original Development Brief – Assists FTA financial assistance recipients in complying with various Equal Employment Opportunity regulations and statutes, including the Genetic Information Nondiscrimination Act.
Original Development Brief – Expands restrictions surrounding human stem cell research in animals and establishes a new NIH steering committee to advise internal agency stakeholders on chimera research funding.
Original Development Brief – Rules on the patentability of identified gene sequences by biotech companies that has reconceptualized our understanding of patent application in the field of biotechnology.
Original Development Brief –Amends USAID Agency for International Development Acquisition Regulation (AIDAR) to include a new clause entitled “Nondiscrimination against End-Users of Supplies or Services,” which specifically mentions genetic information.
Original Development Brief – Clarifies the extent to which an employer may offer an inducement to an employee for the employee’s spouse to provide information about the spouse’s manifestation of disease or disorder as part of a health risk assessment administered in connection with an employer-sponsored wellness program.
Original Development Brief – Among other aims, seeks to improve the health of minorities, women and children, by addressing genetics. Among other aims, seeks to improve the health of minorities, women and children, by addressing genetics.
Original Development Brief –Amends multiple elements of the United States Agency for International Development Acquisition Regulation (AIDAR), including creating a requirement that all contracts include a nondiscrimination clause, which addresses genetic information.
Original Development Brief – Provides recommendations for designing, developing and validating NGS-based tests for rare hereditary diseases and addresses the potential for using FDA-recognized standards to demonstrate analytical validity.